Komori
Tpr (6463) · InitiativeAdvanced

Continuation of Research and Development Activities

First written in FY2017-Q1. 23 of 29 entries say "Restated". Latest entry: FY2026.

29entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2018-Q3RestatedFY2021-Q1 – FY2022-Q3RestatedFY2023-Q1 – FY2026-H12016: 220162017: 320172018: 320182019: 320192020: 320202021: 320212022: 420222023: 420232024: 220242025: 120252026: 12026
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

45 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥3,335 million for the TPR Group excluding the FALTEC Group and ¥2,286 million for the FALTEC Group, for a total of ¥5,622 million for the Group.」

    The company recorded research and development expenses of ¥5,622 million and continued technological innovation in the powertrain and frontier fields.
  2. FY2026-H1RestatedAnnual report

    「The Group's total research and development expenses for the interim consolidated accounting period were ¥2,801 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company recorded research and development expenses of ¥2,801 million and explained that there were no material changes in the status of its research and development activities.
  3. FY2025-H1RestatedAnnual report

    「The Group's total research and development expenses for the interim consolidated accounting period were ¥2,700 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed research and development expenses of ¥2,700 million for the interim consolidated accounting period.
  4. FY2024-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥3,815 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company explained that there were no material changes in research and development activities and disclosed research and development expenses of ¥3,815 million for the nine-month period ended in the third quarter.
  5. FY2024-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,543 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company continued its research and development activities and disclosed first-half research and development expenses of ¥2,543 million, along with no material changes in the status of those activities.
  6. FY2024-Q1RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the first quarter were ¥1,277 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company explained that there were no material changes in research and development activities and disclosed cumulative first-quarter research and development expenses of ¥1,277 million.
  7. FY2023RestatedAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥2,819 million for the TPR Group excluding the FALTEC Group and ¥2,448 million for the FALTEC Group, for a total of ¥5,267 million for the Group.」

    The company continued its research and development activities and recorded annual research and development expenses of ¥5,267 million.
  8. FY2023-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥3,943 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company explained that there were no material changes in research and development activities and disclosed research and development expenses of ¥3,943 million for the nine-month period ended in the third quarter.
  9. FY2023-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,636 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed cumulative research and development expenses of ¥2,636 million.
  10. FY2023-Q1RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the first quarter were ¥1,328 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company explained that there were no material changes in research and development activities and disclosed first-quarter research and development expenses of ¥1,328 million.
  11. FY2022AdvancedAnnual report

    「As part of its new materials development, the company has begun manufacturing nanoporous materials and long-length, few-layer CNTs (carbon nanotubes), and is developing composite products tailored to customer needs, rather than materials alone.」

    Research and development activities have progressed from starting production of new materials to supplying samples and developing composite products, and the company recorded research and development expenses of ¥5,328 million.
  12. FY2022-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥4,032 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development expenses of ¥4,032 million and explained that there were no material changes in the status of its research and development activities.
  13. FY2022-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,699 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed cumulative research and development expenses of ¥2,699 million.
  14. FY2022-Q1RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the first quarter were ¥1,332 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company explained that there were no material changes in research and development activities and disclosed first-quarter research and development expenses of ¥1,332 million.
  15. FY2021-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥3,930 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development expenses of ¥3,930 million for the nine-month period ended in the third quarter and explained that there were no material changes in the status of its research and development activities.
  16. FY2021-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,617 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company recorded research and development expenses of ¥2,617 million and explained that there were no material changes in the status of its research and development activities.
  17. FY2021-Q1RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the first quarter were ¥1,259 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company recorded research and development expenses of ¥1,259 million and explained that there were no material changes in the status of its research and development activities.
  18. FY2020AdvancedAnnual report

    「As part of its new materials development, the company has begun manufacturing nanoporous materials, long-length, few-layer CNTs (carbon nanotubes) and water-soluble binders for electrode materials. It is also developing composite products tailored to customer needs, rather than materials alone.」

    Research and development activities have progressed from starting production of new materials to supplying samples and developing composite products.
  19. FY2020-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,905 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed cumulative research and development expenses of ¥2,905 million.
  20. FY2019AdvancedAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥3,390 million for the TPR Group excluding the FALTEC Group and ¥2,618 million for the FALTEC Group, for a total of ¥6,008 million for the Group.」

    Full-year research and development expenses were ¥6,008 million, with specific activities including manufacturing long-length, few-layer CNTs, developing composite products and transferring technology to overseas sites.
  21. FY2019-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥4,339 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed cumulative research and development expenses of ¥4,339 million.
  22. FY2019-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,897 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and disclosed cumulative research and development expenses of ¥2,897 million.
  23. FY2018AdvancedAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥3,192 million for the TPR Group excluding the FALTEC Group and ¥2,374 million for the FALTEC Group, for a total of ¥5,566 million for the Group. The company also plans to begin manufacturing long-length, few-layer carbon nanotubes and to develop composite products tailored to customer needs, in addition to CNT materials.」

    The company invested ¥5,566 million in research and development and reported specific progress, including the start of manufacturing long-length, few-layer carbon nanotubes.
  24. FY2018-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥4,082 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its policy that there were no material changes in research and development activities and reported cumulative research and development expenses of ¥4,082 million.
  25. FY2018-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥2,715 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and reported research and development expenses of ¥2,715 million.
  26. FY2018-Q1RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the first quarter were ¥1,344 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and reported research and development expenses of ¥1,344 million.
  27. FY2017-Q3RestatedAnnual report

    「The Group's total research and development expenses for the nine-month period ended in the third quarter were ¥3,838 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its explanation that there were no material changes in research and development activities and reported cumulative research and development expenses of ¥3,838 million.
  28. FY2017-Q2RestatedAnnual report

    「The Group's total research and development expenses for the six-month period ended in the second quarter were ¥1,657 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company maintained its policy that there were no material changes in research and development activities and reported research and development expenses of ¥1,657 million for the period.
  29. FY2017-Q1First statedAnnual report

    「Group-wide research and development expenses for the first quarter cumulative period were ¥1,222 million. There were no significant changes in the status of the Group's research and development activities during the first quarter cumulative period.」

    No significant changes were made to research and development activities, and first-quarter cumulative R&D expenses were ¥1,222 million.
Moved together

"Developing One-of-a-Kind Products and Pursuing No. 1 Technology" moved the same way as this thread, in the same document, in 5 of its 29 moves.

555443★123456
  1. ★This thread
  2. 1Developing One-of-a-Kind Products and Pursuing No. 1 Technology5×
  3. 2Expansion of New Businesses and Products and Creation of Group Synergies5×
  4. 3Improving Profitability at Overseas Sites and Optimizing Site Operations5×
  5. 4Manufacturing Innovation and No. 1 Regional Competitiveness4×
  6. 5Strengthening Non-Powertrain Businesses to Address Rapid EV Adoption4×
  7. 6Entering the Non-Metallic Materials Industry and Establishing Two Business Pillars3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tpr yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | TPR CO.,LTD. (6463) | Komori